Connection

Silvio Danese to Pyrimidines

Back to Details
This is a "connection" page, showing publications Silvio Danese has written about Pyrimidines.
Silvio Danese
Connection Strength
1.092
Pyrimidines
  1. Positioning Tofacitinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis. Inflamm Bowel Dis. 2018 09 15; 24(10):2106-2112.
    View in: PubMed
    Score: 0.414
  2. Systematic review with network meta-analysis: comparative assessment of tofacitinib and biological therapies for moderate-to-severe ulcerative colitis. Aliment Pharmacol Ther. 2018 02; 47(4):454-465.
    View in: PubMed
    Score: 0.392
  3. Editorial: tofacitinib and biologics for moderate-to-severe ulcerative colitis-what is best in class? Authors' reply. Aliment Pharmacol Ther. 2018 02; 47(4):540-541.
    View in: PubMed
    Score: 0.099
  4. Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis. N Engl J Med. 2017 05 04; 376(18):1723-1736.
    View in: PubMed
    Score: 0.094
  5. JAK inhibition in inflammatory bowel disease. Expert Rev Clin Immunol. 2017 07; 13(7):693-703.
    View in: PubMed
    Score: 0.093
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.